Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement

Canadian Journal of Anesthesia

Volumn 51, Issue 1, 2004, Pages 31-37

  Lemay, Erik ^a   Guay, Joanne ^a   Côté, Christiane ^a   Roy, Alain ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BUPIVACAINE; DALTEPARIN; FENTANYL; HEMOGLOBIN; LOCAL ANESTHETIC AGENT; MIDAZOLAM; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROPOFOL; TRANEXAMIC ACID;

ARTICLE; BLEEDING DISORDER; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; HUMAN; HUMAN CELL; INFUSION; INTRAOPERATIVE PERIOD; PATIENT CODING; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARDIZATION; STATISTICAL ANALYSIS; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; WOUND CLOSURE;

EID: 1542394745     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018543     Document Type: Article

References (23)

1. McSwiney MM, O'Farrell D, Joshi GP, McCarroll SM. Blood transfusion in total hip arthroplasty: Guidelines to eliminate overtransfusion. Can J Anaesth 1993; 40: 222-6.
2. Anonymous. Practice guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84: 732-47.
3. Spahn DR, Casutt M. Eliminating blood transfusions: New aspects and perspectives. Anesthesiology 2000; 93: 242-55.
4. Sharrock NE, Mineo R, Urquhart B, Salvati EA. The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg 1993; 76: 580-4.
5. Janssens M, Joris J, David J, Lemaire R, Lamy M. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology 1994; 80: 23-9.
6. Murkin JM, Shannon NA, Bourne RB, Rorabeck CH, Cruickshank M, Wyile G. Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty. Anesth Analg 1995; 80: 343-8.
7. Dietrich W, Spuath P, Zuuhlsdorf M, et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery: Relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology 2001; 95: 64-71.
8. Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 1981; 673: 75-85.
9. Horrow JC, VanRiper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82: 383-92.
10. Benoni G, Carlsson A, Petersson C, Fredin H. Does tranexamic acid reduce blood loss in knee arthroplasty? Am J Knee Surg 1995; 8: 88-92.
11. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty. A prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg (Br) 1996; 78-B: 434-40.
12. Hiippala S, Strid L, Wennerstrand M, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 1995; 74: 534-7.
13. Howe JP, Sharma V, Cohen AT. Tranexamic acid reduces blood loss after knee arthroplasty (Letter). J Bone Joint Surg (Br) 1996; 78-B: 995-6.
14. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997; 84: 839-44.
15. Jansen AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999; 83: 596-601.
16. Zohar E, Fredman B, Ellis M, Luban I, Stern A, Jedeikin R. A comparative study of the postoperative allogeneic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement. Anesth Analg 1999; 89: 1382-7.
17. Benoni G, Lethagen S, Nilsson P, Fredin H. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 2000; 71: 250-4.
18. Ekback G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000; 91: 1124-30.
19. Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty. A randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001; 72: 442-8.
20. Samama CM, Langeron O, Rosencher N, et al. Aprotinin versus placebo in major orthopedic surgery: A randomized, double-blinded, dose-ranging study. The Hemorragies et Aprotinine en Chirurgie Orthopédique Lourde Study Group. Anesth Analg 2002; 95: 287-93.
21. Johansson T, Lisander B, Ivarsson I. Mild hypothermia does not increase blood loss during total hip arthroplasty. Acta Anaesthesiol Scand 1999; 43: 1005-10.
22. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996; 347: 289-92.
23. Lamy ML, Daily EK, Brichant JF, et al. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. Anesthesiology 2000; 92: 646-56.